224
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Gout and risk of diabetes mellitus: meta-analysis of observational studies

, , ORCID Icon, , , , , & show all
Pages 917-930 | Received 22 Mar 2019, Accepted 20 Nov 2019, Published online: 24 Dec 2019

References

  • Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V., Gilbert, T., & Nuki, G. (2008). Gout in the UK and Germany: Prevalence, comorbidities and management in general practice 2000–2005. Annals of the Rheumatic Diseases, 67(7), 960–966.
  • Arromdee, E., Michet, C. J., Crowson, C. S., O’Fallon, W. M., & Gabriel, S. E. (2002). Epidemiology of gout: Is the incidence rising? The Journal of Rheumatology, 29(11), 2403–2406.
  • Bardin, T., Bouee, S., Clerson, P., Chales, G., Flipo, R. M., Liote, F., … Richette, P. (2016). Prevalence of gout in the adult population of France. Arthritis Care & Research, 68(2), 261–266.
  • Cea Soriano, L., Rothenbacher, D., Choi, H. K., & Garcia Rodriguez, L. A. (2011). Contemporary epidemiology of gout in the UK general population. Arthritis Research & Therapy, 13(2), R39.
  • Chen, S. Y., Chen, C. L., Shen, M. L., & Kamatani, N. (2003). Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford, England), 42(12), 1529–1533.
  • Choi, H. K., De Vera, M. A., & Krishnan, E. (2008). Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford, England), 47(10), 1567–1570.
  • Collier, A., Stirling, A., Cameron, L., Hair, M., & Crosbie, D. (2016). Gout and diabetes: A common combination. Postgraduate Medical Journal, 92(1089), 372–378.
  • Conen, D., Wietlisbach, V., Bovet, P., Shamlaye, C., Riesen, W., Paccaud, F., & Burnier, M. (2004). Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4, 9.
  • Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., & Rao, M. (2011). Global burden of metabolic risk factors of chronic diseases collaborating, national, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 378(9785), 31–40.
  • Dehghan, A., van Hoek, M., Sijbrands, E. J., Hofman, A., & Witteman, J. C. (2008). High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care, 31(2), 361–362.
  • Desai, R. J., Franklin, J. M., Spoendlin-Allen, J., Solomon, D. H., Danaei, G., & Kim, S. C. (2018). An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout. PloS One, 13(2), e0193622.
  • Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.
  • Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560.
  • Hirsch, J. D., Terkeltaub, R., Khanna, D., Singh, J., Sarkin, A., Shieh, M., … Lee, S. J. (2010). Gout disease-specific quality of life and the association with gout characteristics. Patient Related Outcome Measures, 2010, 1–8.
  • Hsu, C. Y., Lin, C. L., & Kao, C. H. (2015). Gout is associated with organic and psychogenic erectile dysfunction. European Journal of Internal Medicine, 26(9), 691–695.
  • Huang, C. C., Huang, P. H., Chen, J. H., Lan, J. L., Tsay, G. J., Lin, H. Y., … Hsu, C. Y. (2015). An independent risk of gout on the development of deep vein thrombosis and pulmonary embolism: A nationwide, population-based cohort study. Medicine, 94(51), e2140.
  • Janssens, H. J., Arts, P. G., Schalk, B. W., & Biermans, M. C. (2017). Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study. Joint, Bone, Spine, 84(1), 59–64.
  • Janssens, H. J., van de Lisdonk, E. H., Bor, H., van den Hoogen, H. J., & Janssen, M. (2003). Gout, just a nasty event or a cardiovascular signal? A study from primary care. Family Practice, 20(4), 413–416. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12876112
  • Joo, K., Kwon, S. R., Lim, M. J., Jung, K. H., Joo, H., & Park, W. (2014). Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. Journal of Korean Medical Science, 29(5), 657–661.
  • Juraschek, S. P., Kovell, L. C., Miller, E. R., 3rd, & Gelber, A. C. (2015). Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care & Research, 67(4), 588–592.
  • Keenan, T., Zhao, W., Rasheed, A., Ho, W. K., Malik, R., Felix, J. F., … Saleheen, D. (2016). Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study. Journal of the American College of Cardiology, 67(4), 407–416.
  • Kim, S. C., Liu, J., & Solomon, D. H. (2015). Risk of incident diabetes in patients with gout: A cohort study. Arthritis & Rheumatology, 67(1), 273–280.
  • Krishnan, E., Akhras, K. S., Sharma, H., Marynchenko, M., Wu, E. Q., Tawk, R., … Shi, L. (2013). Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM, 106(8), 721–729.
  • Krishnan, E., Baker, J. F., Furst, D. E., & Schumacher, H. R. (2006). Gout and the risk of acute myocardial infarction. Arthritis and Rheumatism, 54(8), 2688–2696.
  • Krishnan, E., Pandya, B. J., Chung, L., Hariri, A., & Dabbous, O. (2012). Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: A 15-year follow-up study. American Journal of Epidemiology, 176(2), 108–116.
  • Kumar, S., Gupta, R., & Suppiah, R. (2012). Gout in women: Differences in risk factors in young and older women. The New Zealand Medical Journal, 125(1363), 39–45. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23159900
  • Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2015). Rising burden of gout in the UK but continuing suboptimal management: A nationwide population study. Annals of the Rheumatic Diseases, 74(4), 661–667.
  • Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2016). Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Annals of the Rheumatic Diseases, 75(1), 210–217.
  • Kuo, C. F., Yu, K. H., See, L. C., Chou, I. J., Ko, Y. S., Chang, H. C., … Luo, S. F. (2013). Risk of myocardial infarction among patients with gout: A nationwide population-based study. Rheumatology (Oxford, England), 52(1), 111–117.
  • L’Heveder, R., & Nolan, T. (2013). International Diabetes Federation. Diabetes Research and Clinical Practice, 101(3), 349–351.
  • Lai, H. M., Chen, C. J., Su, B. Y., Chen, Y. C., Yu, S. F., Yen, J. H., … Chang, S. J. (2012). Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. Rheumatology (Oxford, England), 51(4), 715–720.
  • Lee, H. J., Jeong, K. H., Kim, Y. G., Moon, J. Y., Lee, S. H., Ihm, C. G., … Lee, T. W. (2014). Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model. American Journal of Nephrology, 40(1), 56–63.
  • Li, S., Sanna, S., Maschio, A., Busonero, F., Usala, G., Mulas, A., … Nagaraja, R. (2007). The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genetics, 3(11), e194.
  • Lyu, L. C., Hsu, C. Y., Yeh, C. Y., Lee, M. S., Huang, S. H., & Chen, C. L. (2003). A case-control study of the association of diet and obesity with gout in Taiwan. The American Journal of Clinical Nutrition, 78(4), 690–701.
  • Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Journal of Clinical Epidemiology, 62(10), 1006–1012.
  • Niu, S. W., Chang, K. T., Ta, A., Chang, Y. H., Kuo, I. C., Hung, C. C., … Lin, H. Y. (2018). Decreased incidence of diabetes in patients with gout using benzbromarone. Rheumatology (Oxford, England). doi:10.1093/rheumatology/key138
  • Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006). Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Archives of General Psychiatry, 63(5), 530–538.
  • Primatesta, P., Plana, E., & Rothenbacher, D. (2011). Gout treatment and comorbidities: A retrospective cohort study in a large US managed care population. BMC Musculoskeletal Disorders, 12, 103.
  • Rho, Y. H., Lu, N., Peloquin, C. E., Man, A., Zhu, Y., Zhang, Y., & Choi, H. K. (2016). Independent impact of gout on the risk of diabetes mellitus among women and men: A population-based, BMI-matched cohort study. Annals of the Rheumatic Diseases, 75(1), 91–95.
  • Richette, P., Clerson, P., Perissin, L., Flipo, R. M., & Bardin, T. (2015). Revisiting comorbidities in gout: A cluster analysis. Annals of the Rheumatic Diseases, 74(1), 142–147.
  • Robinson, P. C., Merriman, T. R., Herbison, P., & Highton, J. (2013). Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology (Oxford, England), 52(1), 118–126.
  • Roddy, E., & Doherty, M. (2010). Epidemiology of gout. Arthritis Research & Therapy, 12(6), 223.
  • Roddy, E., Muller, S., Hayward, R., & Mallen, C. D. (2013). The association of gout with sleep disorders: A cross-sectional study in primary care. BMC Musculoskeletal Disorders, 14, 119.
  • Roddy, E., Zhang, W., & Doherty, M. (2007). The changing epidemiology of gout. Nature Clinical Practice Rheumatology, 3(8), 443–449.
  • Rodriguez, G., Soriano, L. C., & Choi, H. K. (2010). Impact of diabetes against the future risk of developing gout. Annals of the Rheumatic Diseases, 69(12), 2090–2094.
  • Ryu, S., Song, J., Choi, B. Y., Lee, S. J., Kim, W. S., Chang, Y., … Sung, K. C. (2007). Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Annals of Epidemiology, 17(4), 245–252.
  • Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007). Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. International Journal of Epidemiology, 36(3), 666–676.
  • Schlesinger, N., Radvanski, D. C., Cheng, J. Q., & Kostis, J. B. (2015). Erectile dysfunction is common among patients with gout. The Journal of Rheumatology, 42(10), 1893–1897.
  • Scire, C. A., Manara, M., Cimmino, M. A., Govoni, M., Salaffi, F., Punzi, L., … Collaborators, K. S. (2013). Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: Results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Research & Therapy, 15(5), R101.
  • Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605.
  • Sui, X., Church, T. S., Meriwether, R. A., Lobelo, F., & Blair, S. N. (2008). Uric acid and the development of metabolic syndrome in women and men. Metabolism, 57(6), 845–852.
  • Trifiro, G., Morabito, P., Cavagna, L., Ferrajolo, C., Pecchioli, S., Simonetti, M., … Mazzaglia, G. (2013). Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: A nationwide population-based study. Annals of the Rheumatic Diseases, 72(5), 694–700.
  • Tung, Y. C., Lee, S. S., Tsai, W. C., Lin, G. T., Chang, H. W., & Tu, H. P. (2016). Association between gout and incident type 2 diabetes mellitus: A retrospective cohort study. The American Journal of Medicine, 129(11), 1219 e1217–1219 e1225.
  • Wandell, P., Carlsson, A. C., & Ljunggren, G. (2015). Gout and its comorbidities in the total population of Stockholm. Preventive Medicine, 81, 387–391.
  • Weaver, A. L. (2008). Epidemiology of gout. Cleveland Clinic Journal of Medicine, 75(Suppl 5), S9–12. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18819329
  • Wijnands, J. M., van Durme, C. M., Driessen, J. H., Boonen, A., Klop, C., Leufkens, B., … de Vries, F. (2015). Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: A population-based cohort study. Medicine, 94(32), e1358.
  • Xing, S. C., Wang, X. F., Miao, Z. M., Zhang, X. Z., Zheng, J., & Yuan, Y. (2015). Association of an exon SNP of SLC2A9 gene with hyperuricemia complicated with type 2 diabetes mellitus in the Chinese male han population. Cell Biochemistry and Biophysics, 71(3), 1335–1339.
  • Zeng, X., Zhang, Y., Kwong, J. S., Zhang, C., Li, S., Sun, F., … Du, L. (2015). The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. Journal of Evidence-based Medicine, 8(1), 2–10.
  • Zhu, Y., Pandya, B. J., & Choi, H. K. (2011). Prevalence of gout and hyperuricemia in the US general population: The national health and nutrition examination survey 2007–2008. Arthritis & Rheumatism, 63(10), 3136–3141.
  • Zhu, Y., Pandya, B. J., & Choi, H. K. (2012). Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. The American Journal of Medicine, 125(7), 679–687 e671.
  • Zimmet, P., Alberti, K. G., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865), 782–787.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.